Review Article
Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity
Table 1
Doxorubicin-induced toxic effects in cardiac and extracardiac cells.
| Cell type | Study | Mechanism of toxicity |
| CPCs | De Angelis et al. [48] | Oxidative stress, cell cycle arrest, and apoptosis | CPCs | Piegari et al. [56] | DNA damage and senescence | CPCs | De Angelis et al. [57] | Oxidative stress, senescence, apoptosis, and reduced migratory capacity | CPCs | Piegari et al. [58] | Senescence and apoptosis | CPCs | Lazzarini et al. [59] | Senescence and apoptosis | CPCs | Huang et al. [60] | Senescence and impaired differentiation potential | ECs | Kalivendi et al. [73] | Oxidative stress, NO deficit, and apoptosis | ECs | Kotamraju et al. [74] | Oxidative stress and apoptosis | ECs | Wojcik et al. [72] | Oxidative stress, apoptosis, and reduced elasticity | ECs | Wilkinson et al. [76] | Impaired microvascular permeability | SMCs | Bielak-Zmijewska et al. [78] | Oxidative stress and senescence | SMCs | Murata et al. [79] | DNA damage and apoptosis | SMCs | Murata et al. [80] | Impaired relaxation and apoptosis | CFs | Zhan et al. [81] | Apoptosis | CFs | Cappetta et al. [88] | Profibrotic phenotype | CFs | Marmisolle et al. [94] | Senescence | CFs | Ghosh et al. [95] | Senescence | MSCs | Yang et al. [110] | Apoptosis and decreased secretory function | MSCs | Oliveira et al. [112] | Lower proliferation rate and impaired differentiation potential | MSCs | Buttiglieri et al. [113] | Telomere length shortening and reduced clonogenic potential | EPCs | De Falco et al. [116] | Oxidative stress and senescence | EPCs | Spallarossa et al. [117] | Senescence and reduced migratory capacity | EPCs | Yasuda et al. (2010) | Senescence and defective engraftment |
|
|
CPCs: cardiac progenitor cells; ECs: endothelial cells; SMCs: smooth muscle cells; CFs: cardiac fibroblasts; MSCs: mesenchymal stem cells; EPCs: endothelial progenitor cells.
|